tirzepatide health canada approval approves weight-loss drug for sleep apnea in patients with obesity Big update in pediatric diabetes

This represents 67-80% savings compared to brand-name Mounjaro or Zepbound ($1,069/month)

Therefore, this review aims to synthesize current evidence on the use of GLP-1 RAs in women planning pregnancy, evaluate emerging safety data, and discuss practical clinical approaches for managing these patients

Simultaneously, tirzepatide suppresses glucagon secretion from pancreatic alpha cells in a glucose-dependent fashion

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

In the observational study mentioned earlier, tirzepatide users with diabetes showed a 60% reduced risk of anxiety diagnoses compared to 44% for semaglutide users

These improvements collectively affect cardiometabolic risk factors, though their impact on long-term cardiovascular outcomes awaits confirmation from the ongoing CVOT